1. News
  2. Sector

  3. Pharma & Healthcare

Covidien to buy Somanetics

India Infoline News Service | Mumbai | June 16, 2010 17:06 IST

The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.

Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.






Read more on: Covidien  to  buy  Somanetics   
article
113101301220
Covidien to buy Somanetics
Covidien to buy Somanetics
The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.
http://www.indiainfoline.com/article/news-sector-pharma-healthcare/covidien-to-buy-somanetics-113101301220_1.html
June 16, 2010 17:06 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Covidien to buy Somanetics
Pharma & Healthcare
$rawVideoFileUrl$
$videoPlayerUrl$

 
 
Reports

Another day, another high

India Infoline News Service / 09:04, Jan 22, 2015

The outlook is a flat start. The market will look to scale to new peaks though not much effort is needed for the same. HUL saw a rally and short-covering may have pulled it up further. Speculation is on that its parent will raise stake through an open offer. After the cooling in oil prices, Cairn results will be in focus.

News